Literature DB >> 1452704

Application of rejection criteria for stool ovum and parasite examinations.

A J Morris1, M L Wilson, L B Reller.   

Abstract

We retrospectively determined the yield of 2,015 stool ovum and parasite (O&P) examinations performed over an 11-month period. Two aspects were evaluated: the yield of positive results from multiple specimens per patient versus the result of a single examination, and the yield of positive results from stools submitted after 3 days of hospitalization. There were 131 (6.7%) positive O&P examinations from 75 patients: for 35 patients the single examination was positive; for 18, two of two examinations were positive; and for 15, three of three examinations were positive. The remaining seven patients had at least one negative examination in a series, but pathogenic intestinal parasites were detected in only three of these patients. Seventeen patients with positive O&P examinations were inpatients: seven of nine patients examined for O&P within 3 days of admission had stool specimens that contained recognized pathogens, in contrast to only two of eight patients examined after 3 days of hospitalization. After reviewing the data and informing hospital clinics, wards, and physicians, we instituted the following policy for screening stool specimens submitted for O&P examination. Only one O&P examination was performed for each outpatient visit and for inpatients hospitalized for 3 days or less, and examinations were not performed on stools submitted after 3 days of hospitalization unless the clinician arranged for the examination on the basis of clinical need. Over the 6-month follow-up period, 29.9% of O&P requests were rejected, 22% for patients in hospital for longer than 3 days and 7.9% for multiple O&P requests. Of 265 initially rejected specimens, 22 (8.3%) were examined after the referring physician contacted the laboratory. None of these specimens was positive. We conclude that eliminating O&P examinations of patients hospitalized for more than 3 days and initially performing only one examination per patient significantly reduces the number of examinations performed and reduces laboratory charges without adversely affecting patient care.

Entities:  

Mesh:

Year:  1992        PMID: 1452704      PMCID: PMC270631          DOI: 10.1128/jcm.30.12.3213-3216.1992

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  13 in total

1.  Numbers of Giardia in the feces of infected children.

Authors:  M Danciger; M Lopez
Journal:  Am J Trop Med Hyg       Date:  1975-03       Impact factor: 2.345

2.  Use of pooled formalin-preserved fecal specimens to detect Giardia lamblia.

Authors:  S P Wahlquist; R M Williams; H Bishop; D G Addiss; J M Stewart; R J Finton; D D Juranek; J J Sullivan
Journal:  J Clin Microbiol       Date:  1991-08       Impact factor: 5.948

3.  Laboratory diagnosis of amebiasis.

Authors:  C SWARTZWELDER
Journal:  Am J Clin Pathol       Date:  1952-04       Impact factor: 2.493

4.  Parasitology: diagnostic yield of stool examination.

Authors:  H Senay; D MacPherson
Journal:  CMAJ       Date:  1989-06-01       Impact factor: 8.262

5.  Cost containment of formalin-preserved stool specimens for ova and parasites from outpatients.

Authors:  C S Peters; L Hernandez; N Sheffield; A L Chittom-Swiatlo; F E Kocka
Journal:  J Clin Microbiol       Date:  1988-08       Impact factor: 5.948

6.  Absence of significant differences in intestinal parasite prevalence estimates after examination of either one or two stool specimens.

Authors:  T W Gyorkos; J D MacLean; C G Law
Journal:  Am J Epidemiol       Date:  1989-11       Impact factor: 4.897

7.  Stool diagnosis of giardiasis using a commercially available enzyme immunoassay to detect Giardia-specific antigen 65 (GSA 65).

Authors:  J D Rosoff; C A Sanders; S S Sonnad; P R De Lay; W K Hadley; F F Vincenzi; D M Yajko; P D O'Hanley
Journal:  J Clin Microbiol       Date:  1989-09       Impact factor: 5.948

8.  Inappropriate testing for diarrheal diseases in the hospital.

Authors:  D L Siegel; P H Edelstein; I Nachamkin
Journal:  JAMA       Date:  1990-02-16       Impact factor: 56.272

9.  Evaluation of a commercially available enzyme-linked immunosorbent assay for Giardia lamblia antigen in stool.

Authors:  D G Addiss; H M Mathews; J M Stewart; S P Wahlquist; R M Williams; R J Finton; H C Spencer; D D Juranek
Journal:  J Clin Microbiol       Date:  1991-06       Impact factor: 5.948

10.  Prepatency of giardiasis.

Authors:  A M Jokipii; L Jokipii
Journal:  Lancet       Date:  1977-05-21       Impact factor: 79.321

View more
  25 in total

1.  Utility of multiple-stool-specimen ova and parasite examinations in a high-prevalence setting.

Authors:  C P Cartwright
Journal:  J Clin Microbiol       Date:  1999-08       Impact factor: 5.948

2.  Evaluation of ColorPAC Giardia/Cryptosporidium rapid assay and ProSpecT Giardia/Cryptosporidium microplate assay for detection of Giardia and Cryptosporidium in fecal specimens.

Authors:  M T Katanik; S K Schneider; J E Rosenblatt; G S Hall; G W Procop
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

3.  Coexistence of eosinophilic gastroenteritis and Helicobacter pylori gastritis: causality versus coincidence.

Authors:  M J Muller; G S Sewell
Journal:  Dig Dis Sci       Date:  2001-08       Impact factor: 3.199

Review 4.  Pathology tests: is the time for demand management ripe at last?

Authors:  G Gopal Rao; M Crook; M L Tillyer
Journal:  J Clin Pathol       Date:  2003-04       Impact factor: 3.411

5.  Development, implementation, and impact of acceptability criteria for serologic tests for infectious diseases.

Authors:  John A Crump; Jennifer R Corder; Nancy G Henshaw; L Barth Reller
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

6.  Cost and time savings following introduction of rejection criteria for clinical specimens.

Authors:  A J Morris; L K Smith; S Mirrett; L B Reller
Journal:  J Clin Microbiol       Date:  1996-02       Impact factor: 5.948

7.  Implementation of a Clinical Decision Support Tool for Stool Cultures and Parasitological Studies in Hospitalized Patients.

Authors:  D Nikolic; S S Richter; K Asamoto; R Wyllie; R Tuttle; G W Procop
Journal:  J Clin Microbiol       Date:  2017-09-27       Impact factor: 5.948

8.  Reducing Unnecessary and Duplicate Ordering for Ovum and Parasite Examinations and Clostridium difficile PCR in Immunocompromised Patients by Using an Alert at the Time of Request in the Order Management System.

Authors:  Caitlin C Otto; Susan L Shuptar; Philippe Milord; Connor J Essick; Reshma Nevrekar; Svetlana L Granovsky; Susan K Seo; N Esther Babady; Steven C Martin; Yi-Wei Tang; Melissa S Pessin
Journal:  J Clin Microbiol       Date:  2015-06-10       Impact factor: 5.948

9.  Use of an enzyme immunoassay does not eliminate the need to analyze multiple stool specimens for sensitive detection of Giardia lamblia.

Authors:  K L Hanson; C P Cartwright
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

10.  Comparison of polyvinyl alcohol fixative with three less hazardous fixatives for detection and identification of intestinal parasites.

Authors:  B Jensen; W Kepley; J Guarner; K Anderson; D Anderson; J Clairmont; W De L'aune; E H Austin; G E Austin
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.